OBJECTIVE	To help address this question , a double-blind , randomised , controlled , multicentre trial was designed to evaluate the efficacy and tolerability of cholinesterase inhibitor treatment in patients with moderate to moderately-severe Alzheimer 's disease over a 2-year period .\